The healthcare data firm reported Q1 2026 revenue of $55.9 million and adjusted EBITDA margin of 27%, exceeding guidance.
Definitive Healthcare Corp. (DH) forecasted full-year 2026 revenue between $220 million and $226 million, while guiding Q2 EBITDA margin to 24%-26%. The outlook follows a mixed Q1 2026 performance, where revenue declined 6% year-over-year to $55.9 million.
Adjusted EBITDA for the quarter reached $15.3 million, or 27% margin, surpassing the high end of guidance by $2.3 million. The company attributed the margin strength to operational efficiencies despite lower revenue.
Management did not disclose immediate market reactions, but the guidance reflects confidence in margin stability amid revenue headwinds.